ANTX
AN2 Therapeutics Inc
4.80$
-2.6%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 92.0% | 96.2% | 79.6% | 93.7% | 96.8% | |
| 98.2% | 96.1% | 18.5% | 26.5% | 11.3% | 23.2% | 32.2% | |
| 98.2% | 96.1% | 89.6% | 93.7% | 77.3% | 90.8% | 93.6% | |
| – | – | – | – | 1.0% | 0.3% | 1.5% | |
| 15.6% | 35.0% | 5.2% | 7.0% | 10.1% | 11.1% | 14.4% | |
| 2.8% | 34.5% | 5.2% | 7.0% | 10.1% | 11.1% | 14.1% | |
| – | – | – | 0.1% | – | – | – | |
| 0.9% | 3.1% | 1.6% | 2.1% | 1.9% | 3.6% | 4.9% | |
| 84.4% | 65.0% | 94.8% | 93.0% | 89.9% | 88.9% | 85.6% | |
| -101.8% | -479.9% | -72.5% | -87.5% | -111.3% | -223.5% | -388.9% | |
| 328.8% | 442.6% | 28.7% | 15.0% | 17.0% | 32.4% | 48.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.